Rexahn Pharmaceuticals, Inc. 8-K Dec. 12, 2017 4:20 PM
FORM 8-K | Current report REXAHN PHARMACEUTICALS, INC. (Form: 8-K, Received: 12/12/2017 16:22:07) SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2017 Rexahn Pharmaceuticals, Inc.
Name: Tae Heum Jeong
Continent: North America
Country: USA
Company: Rexahn Pharmaceuticals, Inc.
Branch: Pharma
Position: CFO & VP
Reason: Resigned
Announcement Date: December 11, 2017, 11:00pm
Resignation Date: December 11, 2017, 11:00pm
Source 1: https://seekingalpha.com/filing/3807624